<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04707443</url>
  </required_header>
  <id_info>
    <org_study_id>(2020)288</org_study_id>
    <nct_id>NCT04707443</nct_id>
  </id_info>
  <brief_title>Enteral Nutrition in Infants With Ileostomy</brief_title>
  <official_title>Prognosis of Donor Human Milk and Extensive Hydrolyzed Formula in Infants With Ileostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, single-center, practical, randomized controlled, parallel and&#xD;
      open clinical study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 112 non-breastfed infants with ileostomy who are prepared for enteral nutrition&#xD;
      will be enrolled. They will be randomly divided into donor milk group and extensively&#xD;
      hydrolyzed formula group. To investigate the effects of different enteral nutrients on the&#xD;
      growth and development of infants with ileostomy, evaluate and compare the effectiveness of&#xD;
      extensively hydrolyzed formula and donor human milk, and the effects on postoperative&#xD;
      intestinal permeability, ostomy fluid volume, intestinal microbiome and metabolites,&#xD;
      septicemia, colitis and cholestasis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 8, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A total of 112 non-breastfed inpatients who are prepared for enteral nutrition after small intestinal fistula will be enrolled. They will be randomly divided into donor milk group and extensively hydrolyzed formula group.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Z-scores of body weight</measure>
    <time_frame>4 weeks after enteral feeding</time_frame>
    <description>The patient will be weighed in the recumbent position on an electronic infant scale. Z-scores for weight for age (WAZ) was obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Z-scores of body length</measure>
    <time_frame>4 weeks day after enteral feeding</time_frame>
    <description>The patient's body length will be measured on the electronic infant scale. Z-scores for weight for age (WAZ) was obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of ostomy volume</measure>
    <time_frame>From the the day starting the enteral nutrition to the forth week.</time_frame>
    <description>The amount of fistula form the ostomy bag will be recorded at the first day, the 14th day and the 28th day of the enteral nutrition.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Nutrition of Ileostomy Infants</condition>
  <arm_group>
    <arm_group_label>donor human milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For patients who can be fed orally or through tubes after surgery, donor milk will be used to feeding for 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>extensively hydrolyzed formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For patients who can be fed orally or through tubes after surgery, extensively hydrolyzed formula will be used to feeding for 4 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>donor human milk</intervention_name>
    <description>Donor human milk: from our center's milk bank&#xD;
Starting dose: 10-20 ml/kg/day (specific according to the amount of fistula or excrement).&#xD;
Evaluate twice every 24 hours, observe for at least 24 hours before volume advancement.&#xD;
Target dose: 150mL/kg/d (energy: 100 to 140 kcal/kg/d).&#xD;
Duration: from the first day when the patient start enteral feeding to the 28th day, lasting for four weeks.</description>
    <arm_group_label>donor human milk</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>extensively hydrolyzed formula</intervention_name>
    <description>eHFï¼šcommercial formulation, distribution from enteral nutrition preparation room of our center&#xD;
Starting dose: 10-20 ml/kg/day (specific according to the amount of fistula or excrement).&#xD;
Evaluate twice every 24 hours, observe for at least 24 hours before volume advancement.&#xD;
Target dose: 150mL/kg/d (energy: 100 to 140 kcal/kg/d).&#xD;
Duration: from the first day when the patient start enteral feeding to the 28th day, lasting for four weeks.</description>
    <arm_group_label>extensively hydrolyzed formula</arm_group_label>
    <other_name>eHF</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  After birth, infants aged 0-6 months (including neonates) undergo small bowel ostomy&#xD;
             for various reasons.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary liver and kidney dysfunction, congenital multiple malformations and&#xD;
             chromosomal abnormalities.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tian Qian, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Children's Hospital of Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tian Qian, M.D.</last_name>
    <phone>02164931981</phone>
    <email>drqiantian@fudan.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yiyao Zhou, Bachelor</last_name>
    <phone>02164931980</phone>
    <email>kerry_zyy@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tian Qian, M.d</last_name>
      <phone>02164931981</phone>
      <email>drqiantian@fudan.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Yiyao Zhou, Bachelor</last_name>
      <phone>02164931980</phone>
      <email>kerry_zyy@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 31, 2020</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2021</study_first_posted>
  <last_update_submitted>October 7, 2021</last_update_submitted>
  <last_update_submitted_qc>October 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Fudan University</investigator_affiliation>
    <investigator_full_name>Qian Tian</investigator_full_name>
    <investigator_title>Deputy Director of clinical Nutrition</investigator_title>
  </responsible_party>
  <keyword>ileostomy</keyword>
  <keyword>Enteral Nutrition</keyword>
  <keyword>Donor human Milk</keyword>
  <keyword>extensively hydrolyzed formula</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

